Lauren Cardella, DO
Vascular Surgery · Traverse City, MINPI 1275950347
Payments from drug & device makers
What this record shows
This record is dominated by grants: $9,000 of the $12,304 with a category attached, or 73.1%. Medtronic accounts for 79.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $5,452 and has fallen 89.6% since, to $570 in 2025.
Across 28 payments — averaging $439.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- Bard Peripheral Vascular, Inc.$2K
- W. L. Gore & Associates, Inc.$661
- Stryker$163
- Endologix LLC$121
- Johnson & Johnson$28
- plus $16 from 1 others
What the payments were for
- Grants$9,00073%
- Travel & lodging$1,28510%
- Food & beverage$1,35811%
- Education$6605%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $9,782 |
| Bard Peripheral Vascular, Inc. | 10 | $1,533 |
| W. L. Gore & Associates, Inc. | 8 | $661 |
| Stryker | 1 | $163 |
| Endologix LLC | 1 | $121 |
| Johnson & Johnson | 1 | $28 |
| Penumbra, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,304 in reported general payments places this provider in the 75th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,038 |
| ClopidogrelClopidogrel Bisulfate | 46 | $763 |
| Cilostazol | 17 | $292 |
| Atorvastatin Calcium | 19 | $250 |
| Rosuvastatin Calcium | 13 | $118 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $29 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Traverse City
- Nicolas MouawadWest Branch$1.7M
- Enrique Criado PallaresMidland$800K
- Jordan KnepperEast Lansing$336K
- Joseph CuppariClinton Township$98K
- Eanas YassaGrand Rapids$81K
- Abedelkarim AbushmaiesBattle Creek$75K
- Kevin OnofreyDetroit$65K
- Yevgeniy RitsDetroit$57K
- Ryan KimSaginaw$50K
- Jimmy HaouilouSaint Clair Shores$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.